Journal of Stem cell Research and Therapy

About the Journal

In today’s era of medical innovation and biological advancement, stem cell research stands at the forefront of regenerative medicine and therapeutic discovery. Stem cells offer unprecedented potential to revolutionize how we understand development, treat disease, and repair damaged tissues. As our understanding of cellular mechanisms deepens, the field of stem cell research continues to unlock transformative approaches in biology and clinical therapy.

The Stem Cell Research and Therapy Journal serves as a dedicated open-access platform for the global scientific community - including researchers, clinicians, academicians, and students -to share pioneering studies and breakthrough findings in stem cell biology and therapeutic applications. It offers insight into a wide spectrum of research areas such as stem cell physiology, cellular reprogramming, tissue engineering, regenerative medicine, organoid technology, gene editing, cell therapy, biomaterials, and clinical translational science.

This interdisciplinary field encompasses research on embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells, hematopoietic stem cells, neural stem cells, and their therapeutic roles in managing diseases like cancer, neurodegenerative disorders, cardiovascular diseases, diabetes, autoimmune conditions, and musculoskeletal regeneration.

The journal welcomes high-quality contributions ranging from molecular mechanisms of stem cell differentiation and proliferation to advanced bioengineering techniques, ethical discussions, and regulatory challenges. It also supports translational and clinical trial reports that evaluate the effectiveness and safety of stem cell-based interventions.

Stem Cell Research and Therapy Journal emphasizes rapid and unbiased peer review, encouraging the timely dissemination of scientific knowledge to promote further research, innovation, and application in the field. The journal’s digital format ensures global visibility and accessibility, facilitating knowledge exchange among researchers and clinicians worldwide.

Manuscripts are processed through an advanced Online Submission System, ensuring streamlined editorial workflow and transparent tracking. Submissions are reviewed by editorial board members or external experts, with final decisions made upon approval from at least two reviewers and the editor.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editor@globalmeetx.net

Rapid Publication Service

Globalmeetx Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.